1997
Scleroderma: A disease related to damaged proteins?
Peng S, Fatenejad S, Craft J. Scleroderma: A disease related to damaged proteins? Nature Medicine 1997, 3: 276-278. PMID: 9055850, DOI: 10.1038/nm0397-276.Peer-Reviewed Original Research
1996
Anti-U5 Small Nuclear Ribonucleoprotein (snRNP) Antibodies: A Rare Anti-U snRNP Specificity
Okano Y, Targoff I, Oddis C, Fujii T, Kuwana M, Tsuzaka K, Hirakata M, Mimori T, Craft J, Medsger T. Anti-U5 Small Nuclear Ribonucleoprotein (snRNP) Antibodies: A Rare Anti-U snRNP Specificity. Clinical Immunology 1996, 81: 41-47. PMID: 8808640, DOI: 10.1006/clin.1996.0155.Peer-Reviewed Original Research
1995
Molecular Structure and Function of Autoantigens in Systemic Sclerosis
Lee B, Craft J. Molecular Structure and Function of Autoantigens in Systemic Sclerosis. International Reviews Of Immunology 1995, 12: 129-144. PMID: 7650417, DOI: 10.3109/08830189509056708.Peer-Reviewed Original ResearchMeSH KeywordsAntigens, NuclearAutoantigensChromosomal Proteins, Non-HistoneDNA HelicasesDNA Topoisomerases, Type IDNA-Binding ProteinsDNA-Directed RNA PolymerasesEndoribonucleasesExoribonucleasesExosome Multienzyme Ribonuclease ComplexHumansKinetochoresKu AutoantigenNuclear ProteinsPol1 Transcription Initiation Complex ProteinsRibonucleoproteinsScleroderma, SystemicTranscription Factors
1993
Identification of autoantibodies to RNA polymerase II. Occurrence in systemic sclerosis and association with autoantibodies to RNA polymerases I and III.
Hirakata M, Okano Y, Pati U, Suwa A, Medsger TA, Hardin JA, Craft J. Identification of autoantibodies to RNA polymerase II. Occurrence in systemic sclerosis and association with autoantibodies to RNA polymerases I and III. Journal Of Clinical Investigation 1993, 91: 2665-2672. PMID: 8390487, PMCID: PMC443330, DOI: 10.1172/jci116505.Peer-Reviewed Original ResearchConceptsSystemic sclerosisII antibodiesAnti-RNA polymerase II antibodiesLimited cutaneous diseaseConnective tissue diseaseIdentification of autoantibodiesSera of patientsIndirect immunofluorescence studiesHuman serumTissue diseaseCutaneous diseaseNormal controlsAutoantibodiesSclerosisPatientsHuman antibodiesRNA polymerase IIClinical perspectiveMonoclonal antibodiesAntibodiesSerumRNA polymerase IImmunofluorescence studiesImmunodepletion studiesFurther studies
1990
The analysis of antinuclear and antinucleolar autoantibodies of scleroderma by radioimmunoprecipitation assays
Kipnis R, Craft J, Hardin J. The analysis of antinuclear and antinucleolar autoantibodies of scleroderma by radioimmunoprecipitation assays. Arthritis & Rheumatism 1990, 33: 1431-1437. PMID: 2403405, DOI: 10.1002/art.1780330917.Peer-Reviewed Original ResearchMeSH KeywordsAntibodies, AntinuclearAntibody SpecificityFemaleHumansMalePrecipitin TestsRadioimmunoassayScleroderma, SystemicConceptsCommon antibody specificitiesPrimary Raynaud's phenomenonScleroderma overlap syndromeOverlap syndromeDiffuse sclerodermaRaynaud's phenomenonRNP antibodiesCREST syndromeAntinucleolar autoantibodiesAmerican patientsRadioimmunoprecipitation assaysAutoantibodiesIndirect immunofluorescenceSclerodermaAntibody specificityNucleolar antigensPatientsSyndromeAntibodiesImmunoprecipitation assaysAssays
1988
The U2 small nuclear ribonucleoprotein particle as an autoantigen. Analysis with sera from patients with overlap syndromes.
Craft J, Mimori T, Olsen TL, Hardin JA. The U2 small nuclear ribonucleoprotein particle as an autoantigen. Analysis with sera from patients with overlap syndromes. Journal Of Clinical Investigation 1988, 81: 1716-1724. PMID: 2968364, PMCID: PMC442616, DOI: 10.1172/jci113511.Peer-Reviewed Original Research